Strengthened Warnings Fracture Risk After Discontinuation Denosumab Prolia AND Biosimilars
TGA (CWLTH) resource. Rules Mate indexes this as part of the Australian compliance corpus. Click through for the regulator's primary source.
https://www.tga.gov.au/news/safety-updates/strengthened-warnings-fracture-risk-after-discontinuation-denosumab-prolia-and-biosimilars
Rules Mate indexes Australian government compliance resources to make them searchable. We link to + summarise; always verify the live source before acting.